![Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases](https://www.strokejournal.org/cms/asset/d34f16a5-a98d-4834-afd8-0fe7483b7ef0/gr1.jpg)
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases
![Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke](https://www.ahajournals.org/cms/asset/59444155-3a95-4d91-bbd5-32c425bec925/1140fig01.gif)
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE
![The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology](https://www.acc.org/-/media/Non-Clinical/Migration-Content/Hot-Topics/Anticoagulation-Management/The-New-Oral-Anticoagulants-in-Atrial-Fibrillation-Once-or-Twice-Daily/AM_HotTopic_Dec13_Table1.gif?la=en&hash=CDD5776702B830B601B0A7851CB554A1B900CBA6)
The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology
![Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720361052-fx1.jpg)
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect
![Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fc8073074af9c50576c23cf71f14d56e2ae1ba82/6-Figure3-1.png)
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar
![Pharmaceutics | Free Full-Text | Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation Pharmaceutics | Free Full-Text | Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-01744/article_deploy/html/images/pharmaceutics-14-01744-g001.png)
Pharmaceutics | Free Full-Text | Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation
![Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study - Staerk - 2018 - Journal of Internal Medicine - Wiley Online Library Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study - Staerk - 2018 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c89b4638-8e3a-43d3-93c3-6c0030c3a41c/joim12683-fig-0001-m.jpg)
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study - Staerk - 2018 - Journal of Internal Medicine - Wiley Online Library
![Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717370067-gr5.jpg)
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect
![What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon, Hyung Wook Park, Jeong Gwan Cho, What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon, Hyung Wook Park, Jeong Gwan Cho,](https://journals.sagepub.com/cms/10.1177/10760296211061148/asset/images/large/10.1177_10760296211061148-fig1.jpeg)
What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon, Hyung Wook Park, Jeong Gwan Cho,
![Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b141e8c36fd0ceaec628488a500cd5aad3141e4d/4-Table1-1.png)
Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar
![Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9157d42f3c05295de4cc1cf1fa45be4bda52f85b/2-Figure1-1.png)
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar
![The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation - ScienceDirect The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167527317378087-gr1.jpg)